DrugCite
Search

AGGRASTAT

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Aggrastat Adverse Events Reported to the FDA Over Time

How are Aggrastat adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Aggrastat, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Aggrastat is flagged as the suspect drug causing the adverse event.

Most Common Aggrastat Adverse Events Reported to the FDA

What are the most common Aggrastat adverse events reported to the FDA?

Thrombocytopenia
191 (9.6%)
Myocardial Infarction
64 (3.22%)
Cardiogenic Shock
46 (2.31%)
Haemorrhage
43 (2.16%)
Death
42 (2.11%)
Cerebral Haemorrhage
40 (2.01%)
Haemoglobin Decreased
39 (1.96%)
Coronary Artery Stenosis
34 (1.71%)
Acute Myocardial Infarction
33 (1.66%)
Thrombosis In Device
24 (1.21%)
Haematoma
23 (1.16%)
Show More Show More
Hypotension
21 (1.06%)
Post Procedural Complication
21 (1.06%)
Haematocrit Decreased
19 (.95%)
Off Label Use
18 (.9%)
Anaemia
17 (.85%)
Cardiac Failure
17 (.85%)
Renal Failure
17 (.85%)
Ventricular Fibrillation
17 (.85%)
Gastrointestinal Haemorrhage
16 (.8%)
Pulmonary Haemorrhage
16 (.8%)
Chest Pain
15 (.75%)
Drug Ineffective
14 (.7%)
Haemoptysis
14 (.7%)
Acute Coronary Syndrome
13 (.65%)
Platelet Count Decreased
13 (.65%)
Shock Haemorrhagic
13 (.65%)
Blood Glucose Increased
12 (.6%)
Cardiac Arrest
12 (.6%)
Cerebrovascular Accident
12 (.6%)
Petechiae
12 (.6%)
Pyrexia
12 (.6%)
Chills
11 (.55%)
Ejection Fraction Decreased
11 (.55%)
Overdose
11 (.55%)
Post Procedural Haemorrhage
11 (.55%)
Vomiting
11 (.55%)
Drug Specific Antibody Present
10 (.5%)
Haematuria
10 (.5%)
Haemorrhage Intracranial
10 (.5%)
Pericardial Effusion
10 (.5%)
Renal Failure Acute
10 (.5%)
Coronary Artery Thrombosis
9 (.45%)
Sepsis
9 (.45%)
Shock
9 (.45%)
Dyspnoea
8 (.4%)
Hemiparesis
8 (.4%)
Nausea
8 (.4%)
Pulmonary Alveolar Haemorrhage
8 (.4%)
Respiratory Failure
8 (.4%)
Retroperitoneal Haemorrhage
8 (.4%)
Acute Pulmonary Oedema
7 (.35%)
Arrhythmia
7 (.35%)
Cardiac Tamponade
7 (.35%)
Coronary Artery Occlusion
7 (.35%)
Depressed Level Of Consciousness
7 (.35%)
Haematemesis
7 (.35%)
Haemodynamic Instability
7 (.35%)
Haemolysis
7 (.35%)
Haemothorax
7 (.35%)
Hypovolaemic Shock
7 (.35%)
Puncture Site Haemorrhage
7 (.35%)
Ventricular Tachycardia
7 (.35%)
Aphasia
6 (.3%)
Brain Stem Infarction
6 (.3%)
Condition Aggravated
6 (.3%)
Coronary Artery Disease
6 (.3%)
Electrocardiogram St Segment Depres...
6 (.3%)
Epistaxis
6 (.3%)
General Physical Health Deteriorati...
6 (.3%)
Infusion Site Haemorrhage
6 (.3%)
Liver Function Test Abnormal
6 (.3%)
Pericarditis
6 (.3%)
Procedural Complication
6 (.3%)
Respiratory Tract Haemorrhage
6 (.3%)
Troponin T Increased
6 (.3%)
Activated Partial Thromboplastin Ti...
5 (.25%)
Angina Pectoris
5 (.25%)
Angina Unstable
5 (.25%)
Cardiac Procedure Complication
5 (.25%)
Cardio-respiratory Arrest
5 (.25%)
Catheter Site Haemorrhage
5 (.25%)
Disseminated Intravascular Coagulat...
5 (.25%)
Drug Hypersensitivity
5 (.25%)
Electromechanical Dissociation
5 (.25%)
Fall
5 (.25%)
Hepatic Failure
5 (.25%)
Iatrogenic Injury
5 (.25%)
Left Ventricular Failure
5 (.25%)
Medication Error
5 (.25%)
Multi-organ Failure
5 (.25%)
Pain
5 (.25%)
Pleural Haemorrhage
5 (.25%)
Pulmonary Embolism
5 (.25%)
Pulmonary Oedema
5 (.25%)
Rectal Haemorrhage
5 (.25%)
Septic Shock
5 (.25%)
Stent Occlusion
5 (.25%)
Subdural Haematoma
5 (.25%)
Tremor
5 (.25%)
Troponin I Increased
5 (.25%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Aggrastat, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Aggrastat is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Aggrastat

What are the most common Aggrastat adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Aggrastat, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Aggrastat is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Aggrastat According to Those Reporting Adverse Events

Why are people taking Aggrastat, according to those reporting adverse events to the FDA?

Acute Coronary Syndrome
124
Acute Myocardial Infarction
104
Angina Unstable
93
Myocardial Infarction
51
Coronary Angioplasty
41
Drug Use For Unknown Indication
22
Show More Show More
Cardiac Enzymes Increased
20
Cerebrovascular Accident
15
Antiplatelet Therapy
10
Ischaemic Stroke
6
Chest Pain
6
Thrombosis
6
Percutaneous Coronary Intervention
6
Angioplasty
6
Angina Pectoris
6
Cerebral Haemorrhage
5
Coronary Artery Thrombosis
5
Anticoagulant Therapy
5
Coronary Arterial Stent Insertion
5
Electrocardiogram St Segment Depres...
5
Cerebral Thrombosis
4
Electrocardiogram St Segment Elevat...
4
Prophylaxis
4
Premedication
4
Product Used For Unknown Indication
4
Coronary Artery Disease
4
Infarction
3
Platelet Aggregation Inhibition
3
Thrombocytopenia
2
Myocardial Ischaemia
2
Thrombosis Prophylaxis
2
Cardiovascular Event Prophylaxis
2
Catheterisation Cardiac
2
Stent Placement
2
Preoperative Care
2
Cerebral Artery Occlusion
2
Ischaemic Heart Disease Prophylaxis
2
Basilar Artery Thrombosis
1
Vasodilation Procedure
1
Platelet Aggregation
1
Basilar Artery Occlusion
1
Electrocardiogram Change
1
Coronary Artery Surgery
1
Troponin Increased
1
Enzyme Abnormality
1
Cerebral Artery Stenosis
1
Cardiac Infection
1
Arteriogram Coronary
1
Cerebral Infarction
1
Electrocardiogram T Wave Inversion
1
Vascular Graft Occlusion
1

Drug Labels

LabelLabelerEffective
AggrastatMedicure International Inc05-APR-12

Aggrastat Case Reports

What Aggrastat safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Aggrastat. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Aggrastat.